Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
Arlene Chan
◽
Beverly Moy
◽
Janine Mansi
◽
Bent Ejlertsen
◽
Frankie Ann Holmes
◽
...
2019 ◽
Vol 44
◽
pp. S18-S19
B. Ejlertsen
◽
F.A. Holmes
◽
S.K.L. Chia
◽
H. Iwata
◽
B. Moy
◽
...
SKL Chia
◽
M Martin
◽
H Iwata
◽
B Moy
◽
AS Lalani
◽
...
M Gnant
◽
M Martin
◽
F-A Holmes
◽
C Jackisch
◽
SK Chia
◽
...
Lorenzo Livi
◽
Isacco Desideri
2013 ◽
Vol 93
(1)
◽
pp. 114-121
◽
Deb Feldman-Stewart
◽
Yolanda Madarnas
◽
Mihaela Mates
◽
Christine Tong
◽
Eva Grunfeld
◽
...
2019 ◽
Vol 19
(3)
◽
pp. e475-e480
Jordan Henderson
◽
Paul Adams
◽
Kimberly Barber
2019 ◽
Vol 22
◽
pp. S96-S97
J. Jayasekera
◽
J. Mandelblatt
◽
S. O'Neill
◽
C. Schechter
2019 ◽
Vol 105
(4)
◽
pp. 795-802
◽
Samantha M. Buszek
◽
Heather Y. Lin
◽
Isabelle Bedrosian
◽
Nina Tamirisa
◽
Gildy V. Babiera
◽
...
2008 ◽
Vol 17
(6)
◽
pp. 631-636
◽
Mario Valenzano Menada
◽
Sergio Costantini
◽
Melita Moioli
◽
Stefano Bogliolo
◽
Andrea Papadia
◽
...
2017 ◽
Vol 167
(1)
◽
pp. 235-248
◽
Kirsten A. Nyrop
◽
Allison M. Deal
◽
Jordan T. Lee
◽
Hyman B. Muss
◽
Seul Ki Choi
◽
...